drugset / Trial / NCT04390009
Entire-body PET Scans for Multiple Sclerosis
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.
Timeline
- Start
- 2024-09-30
- Primary completion
- 2025-09-30
- Completion
- 2025-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | florbetapir F 18 | Diagnostic / imaging agent | — | — |